Glioblastoma Pipeline Landscape Report 2024: Pivotal Advances in Treatment Protocols and Drug Developments
April 26, 2024 04:35 ET
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest report on the Glioblastoma pipeline...
Glioblastoma Multiforme (GBM) Global Clinical Trials Review 2024, by Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
April 03, 2024 11:27 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical...
Glioblastoma Multiforme Market Analysis Report 2023: Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecasts, 2021-2031
April 14, 2023 08:28 ET
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial...
Global Glioblastoma Multiforme Treatment Markets Analysis & Forecasts, 2017-2020 & 2021-2028
December 01, 2021 05:13 ET
|
Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Radiation Therapy, Immunotherapy), By Drug Class, By...